GD-GABAPENTIN
GENMED A DIVISION OF PFIZER CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is GD-GABAPENTIN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that GD-GABAPENTIN 300MG has been permanently discontinued (last updated January 14, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is GD-GABAPENTIN not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-GABAPENTIN
APOTEX INC
Other Products
NEURONTIN
BGP PHARMA ULC
GABAPENTIN
OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.
TEVA-GABAPENTIN
TEVA CANADA LIMITED
NTP-GABAPENTIN
TEVA CANADA LIMITED
DOM-GABAPENTIN
DOMINION PHARMACAL
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02285827
Strength
300MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
GABAPENTIN
Tier
Unrated
Last Updated
2019-01-14
Reason for Shortage
Business reasons